Company / Operating Income per Share
Esperion Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.29
FY2025
5-year range
-$8.37 / $0.29
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
#49 of 201
Health Care
What the data says
Esperion Therapeutics, Inc.'s operating income per share of $0.29 is higher than 76% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-8.37 in FY2021 to $0.29 in FY2024.
Based on SEC 10-K filings.
0.29 in FY2025. Top quartile in the Health Care sector.
Improved from $-1.51 to $0.29 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+101.0% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 0.2% year-over-year.
- Ranks #49 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | -0.2% |
| FY2024 | $0.29 | +119.3% |
| FY2023 | -$1.51 | +44.2% |
| FY2022 | -$2.70 | +67.7% |
| FY2021 | -$8.37 | -89.6% |
| FY2020 | -$4.41 | -27.2% |
| FY2019 | -$3.47 | +54.6% |
| FY2018 | -$7.65 | -8.3% |
| FY2017 | -$7.06 | -109.0% |
| FY2016 | -$3.38 | -48.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026